Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Participant likelihood to use, purchase, & pay for alternative products.(N = 44)

From: US smokers' reactions to a brief trial of oral nicotine products

  Preferred product (Overall) Camel Snus Marlb Snus Stone-wall Commit 4 mg Test/p-value*
Likely to use instead of cigarettes (%)
Very 20.5 14.3 15.4 0 31.6 χ2(6) = 96.4
Somewhat 45.5 42.9 46.2 40 47.4 p = 0.584
Not at all 34.1 42.9 38.5 60 21.1  
Likely to use in addition to cigarettes (%)
Very 47.7 71.4 23.1 40 57.9 χ2(6) = 52.6
Somewhat 38.6 28.6 53.8 40 31.6 p = 0.396
Not at all 13.6 0 23.1 20 10.5  
Likely to purchase in next year (%)
Very 38.6 28.6 30.8 0 57.9 χ2(6) = 12.7
Somewhat 40.9 42.9 46.2 60 31.6 p = 0.302
Not at all 20.5 28.6 23.1 40 10.5  
Price willing to pay for one package ($)
Median 5 3 3 2 5 χ2(3) = 11.81
(IQR) (3.00-5.75) (2.00-3.00) (2.50-5.00) (1.00-4.00) (5.00-11.00) p < 0.001
  1. * Likelihood variables tested by Pearson chi-square; price tested by Kruskal-Wallis